Page last updated: 2024-08-17

17-alpha-hydroxyprogesterone and Benign Cranial Nerve Neoplasms

17-alpha-hydroxyprogesterone has been researched along with Benign Cranial Nerve Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Comite, F; Cutler, GB; Hench, K; Laue, L; Loriaux, DL; Pescovitz, OH1

Other Studies

1 other study(ies) available for 17-alpha-hydroxyprogesterone and Benign Cranial Nerve Neoplasms

ArticleYear
Precocious puberty associated with neurofibromatosis and optic gliomas. Treatment with luteinizing hormone releasing hormone analogue.
    American journal of diseases of children (1960), 1985, Volume: 139, Issue:11

    Topics: 17-alpha-Hydroxyprogesterone; Child; Child, Preschool; Chorionic Gonadotropin; Cortodoxone; Cranial Nerve Neoplasms; Estradiol; Female; Follicle Stimulating Hormone; Glioma; Gonadotropin-Releasing Hormone; Growth; Humans; Hydroxyprogesterones; Luteinizing Hormone; Male; Neurofibromatosis 1; Optic Nerve Diseases; Puberty, Precocious; Skin Neoplasms; Testosterone; Triptorelin Pamoate

1985